ArticleMedical physics2026
Single-field-uniform-dose-per-fraction simultaneous dose and dose rate optimization (SFUDPF-SDDRO) method for proton FLASH therapy.
Article in Medical physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
backgroundThe FLASH effect can significantly reduce radiation-induced normal tissue damage while maintaining tumour control, but requires ultra-high dose rates and high doses. PURPOSE: This work proposes a single-field-uniform-dose-per-fraction simultaneous dose and dose rate optimization (SFUDPF-SDDRO) method for proton FLASH radiotherapy to ensure both dose rate and dose meet FLASH effect thresholds.
methodsThe SFUDPF method focuses on delivering the prescription dose for each fraction from only a single field instead of multiple fields, which inherently supports the ultra-high dose rate and high dose necessary for the FLASH effect. We performed retrospective FLASH treatment planning utilizing SFUDPF-SDDRO on four clinical head-and-neck (HN) cases for this study. SFUDPF planning involves delivering each prescription fraction (8 Gy x 5 fx) in 1 beam angle as opposed to multiple beam angles per fraction for IMPT. For each beam delivery, we maximized the FLASH effect in a 1 cm expansion of the HN CTV (CTV+1 cm) by enforcing FLASH dose-rate and dose thresholds of 40 Gy/s and 5 Gy, respectively, in this region. The pencil-beam-scanning dose rate (PBSDR) was calculated voxel-wise by modeling the raster-scanning spot trajectory, while neglecting energy switching times under the assumption of a range modulator capable of expanding a single-energy beam into a spread-out Bragg peak (SOBP). Robust optimization at 3 mm/3.5% was performed to address setup and range uncertainties. We employed iterative convex relaxation and alternating direction method of multipliers algorithms to solve the non-convex optimization problem posed by the SFUDPF-SDDRO model. The FLASH effect was modelled within this work by multiplying the proton dose with a constant 0.7 dose modification factor for voxels fulfilling the dose-rate and dose thresholds to obtain the FLASH effective dose (FED). Effects of FLASH sparing maximization via SFUDPF-SDDRO are verified by comparing with IMPT and VMAT on plan qualities such as (i) high-dose area sparing, (ii) conformity index (CI), and (iii) OAR doses.
resultsFLASH RT via SFUDPF-SDDRO compared with IMPT and VMAT was evaluated for four clinical HN cases with different tumor geometries. When compared with their VMAT counterparts, SFUD-SDDRO achieved a considerable reduction of FED for OAR directly adjacent to the CTV. Specifically in case 1, the brainstem D
conclusionThe proposed SFUDPF-SDDRO method is feasible and shows potential clinical benefits for FLASH treatment planning. Maximizing the FLASH effect within a 1 cm ring around the target substantially limits high-dose spillage and enhances OAR sparing compared with conventional approaches.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.